Novo Nordisk A/S (NYSE:NVO) has partnered with Anthropic to use Claude models and Claude Science in its research and ...
Novo Nordisk enters into a collaboration with Anthropic toaccelerate the development of new medicines through Claude.
The Danish drugmaker will use Claude Science and Anthropic's frontier models to tackle drug discovery challenges and ...
The Danish pharmaceutical company is best known for the weight-loss drug Wegovy. Its latest partnership aims to find the next ...
The Ozempic maker is partnering with the AI firm to speed up drug development.
Asianet Newsable on MSN
Novo Nordisk taps Anthropic’s Claude Science to speed up drug discovery — here’s everything investors need to know
Novo will use Anthropic’s Claude Science in R&D to tackle scientific and drug discovery challenges, aiming to develop new ...
Novo Nordisk (NVO) stock rose 4% after announcing an Anthropic AI deal and receiving a European approval recommendation for ...
Novo Nordisk (NVO) stock jumped 4% after unveiling an AI collaboration with Anthropic and securing European approval recommendation for Frehemgo.
The pharmaceutical company will test Claude Science in research and development workflows and use Anthropic’s models to ...
Novo Nordisk and Anthropic announced a collaboration to deploy Claude Science and other frontier AI models to speed up drug ...
Novo Nordisk and Anthropic announced a collaboration on September 16, 2026, under which the drugmaker will use Anthropic's frontier AI models and test the Claude Science workbench in specific research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results